This opinion article is endorsed by the World Endometriosis Society (WES) and the International Federation of Fertility Societies (IFFS)
The COVID-19 pandemic has led to a dramatic shift in the clinical
practice of women’s health and routine care for endometriosis has been
severely disrupted. Endometriosis is defined as an inflammatory disease
characterised by lesions of endometrial-like tissue outside the uterus
that is associated with pelvic pain and/or
infertility.1 It affects approximately 10% of
reproductive age women worldwide, is diagnosed by surgically
visualisation or by radiological imaging, and is treated with hormone
treatments or by laparoscopic removal of lesions.2,3
Under the guidance of international gynaecological
organisations4–6, many centres have temporarily
ceased offering outpatient appointments, diagnostic imaging for
non-acute pelvic pain, surgery for endometriosis, and fertility
treatments. This means that endometriosis sufferers are be feeling
particularly vulnerable and that resultant stress and anxiety may
contribute to a worsening of symptoms. The pandemic poses several
important questions for healthcare providers on how best to deliver care
with these restrictions. Herein, we present clinical guidance on the
management of endometriosis during the COVID-19 pandemic (Fig. 1).